These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 8563872

  • 1. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T, Iwao Y, Yajima T, Inoue N, Ueno Y, Takaishi H, Watanabe M, Ishii H.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
    [Abstract] [Full Text] [Related]

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 5. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM, Iser JH, Gibson PR.
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [Abstract] [Full Text] [Related]

  • 6. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
    Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
    [Abstract] [Full Text] [Related]

  • 7. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease.
    Korelitz BI, Fuller SR, Warman JI, Goldberg MD.
    Am J Gastroenterol; 1999 Feb; 94(2):424-6. PubMed ID: 10022640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [Abstract] [Full Text] [Related]

  • 10. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 11. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 12. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 13. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
    Seibold F, Wagner AC, Göke B.
    Schweiz Med Wochenschr; 2000 Feb 19; 130(7):222-32. PubMed ID: 10719713
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease].
    Hinojosa J, Molés JR, Nos P, Hoyos M, Ramírez JJ, Primo J, Fernández J, Berenguer J.
    Rev Esp Enferm Dig; 1995 Nov 19; 87(11):775-80. PubMed ID: 8534531
    [Abstract] [Full Text] [Related]

  • 15. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A.
    Wien Klin Wochenschr; 1998 Sep 04; 110(16):579-84. PubMed ID: 9782579
    [Abstract] [Full Text] [Related]

  • 16. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 04; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 17. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun 04; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

  • 18. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
    Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):319-30. PubMed ID: 16842459
    [Abstract] [Full Text] [Related]

  • 19. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
    Glas J, Török HP, Daczo J, Tonenchi L, Folwaczny M, Folwaczny C.
    Eur J Med Res; 2005 Dec 07; 10(12):535-8. PubMed ID: 16356870
    [Abstract] [Full Text] [Related]

  • 20. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM.
    J Pediatr; 2000 Dec 07; 137(6):794-9. PubMed ID: 11113835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.